Cardiac diseases in AIDS pathophysiology: Difference between revisions
No edit summary |
|||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Many observational studies have shown that HIV-infected patients are at an increased risk for developing a variety of cardiac diseases. With the introduction of [[HAART]], longevity of [[HIV]]-infected patients increased, in turn leading to increased prevalence of cardiac and allied diseases. [[Inflammation]] and immune regulation leading to atherogenesis, endothelial dysfunction and coagulation abnormalities have been proposed as the major factors in the pathogenesis of cardiovascular diseases in [[AIDS]]. Compared to age-matched uninfected controls, HIV-infected patients have a higher risk of [[myocardial infarction]] ([[MI]]) and cardiovascular death, even with effective anti-retroviral therapy. | |||
Many observational studies have shown that HIV-infected patients are at an increased risk for developing a variety of cardiac diseases. With the introduction of HAART, longevity of HIV-infected patients increased, in turn leading to increased prevalence of cardiac and allied diseases. Inflammation and immune regulation leading to atherogenesis, endothelial dysfunction and coagulation abnormalities have been proposed as the major factors in the pathogenesis of cardiovascular diseases in AIDS. Compared to age-matched uninfected controls, HIV-infected patients have a higher risk of myocardial infarction and cardiovascular death, even with effective anti-retroviral therapy. | |||
==Pathophysiology== | ==Pathophysiology== | ||
Revision as of 21:40, 28 June 2013
|
Cardiac diseases in AIDS Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Cardiac diseases in AIDS pathophysiology On the Web |
|
American Roentgen Ray Society Images of Cardiac diseases in AIDS pathophysiology |
|
Risk calculators and risk factors for Cardiac diseases in AIDS pathophysiology |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [2]
Overview
Many observational studies have shown that HIV-infected patients are at an increased risk for developing a variety of cardiac diseases. With the introduction of HAART, longevity of HIV-infected patients increased, in turn leading to increased prevalence of cardiac and allied diseases. Inflammation and immune regulation leading to atherogenesis, endothelial dysfunction and coagulation abnormalities have been proposed as the major factors in the pathogenesis of cardiovascular diseases in AIDS. Compared to age-matched uninfected controls, HIV-infected patients have a higher risk of myocardial infarction (MI) and cardiovascular death, even with effective anti-retroviral therapy.